Literature DB >> 31264216

Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells.

Masoud Shirmohamadi1, Elham Eghbali2, Shiva Najjary3, Ahad Mokhtarzadeh3, Amir Baghbanzadeh Kojabad3, Khalil Hajiasgharzadeh3, Parisa Lotfinezhad3,4, Behzad Baradaran3.   

Abstract

Colorectal cancer (CRC) is one of the most lethal and hard-to-treat cancers in the world, which in its advanced stages, surgery and chemotherapy are the main common treatment approaches. The microRNAs (miRNAs), as novel markers for CRC detection, promote their regulatory effects via the 3'-untranslated binding region (3'-UTR) of target messenger RNA in posttranscriptional regulation of genes and also play a pivotal role in modulating resistance to chemotherapeutic agents. These small noncoding RNAs have also a critical role in CRC stem cells (CRCSCs) regulation, comprising self-renewal, differentiation, and tumorigenesis. Cancer stem cells (CSCs) are distinctive cell types inside a tumor tissue that are believed to derive from normal somatic stem cells. The CSCs have self-renewal abilities, angiogenesis, as well as specific surface markers expression characteristics. Furthermore, they are frequently criticized for tumor maintenance, treatment resistance, tumor development, and distant metastasis. In this review, we discuss the current understandings of CRCSCs and their environment with a focus on the role of miRNAs on the regulation of CSCs and their targeting application in CRC treatment.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer stem cells; colorectal cancer; miRNAs; regulatory mechanisms

Year:  2019        PMID: 31264216     DOI: 10.1002/jcp.29042

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340.

Authors:  Junfeng Yu; Zhejian Ou; Yangyang Lei; Liuhua Chen; Qiao Su; Kunsong Zhang
Journal:  Hum Cell       Date:  2019-11-27       Impact factor: 4.174

Review 2.  Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review.

Authors:  Mateus de Almeida Rainho; Andre Luiz Mencalha; Alessandra Alves Thole
Journal:  Mol Biol Rep       Date:  2021-10-12       Impact factor: 2.316

3.  ZNF516 suppresses stem cell-like characteristics by regulating the transcription of Sox2 in colorectal cancer.

Authors:  Jifu E; Zhengchun Kang; Jie Yuan; Zhaoming Wang; Dafeng Tong; Junjie Xing
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

4.  Hsa_circ_0001806 Acts as a ceRNA to Facilitate the Stemness of Colorectal Cancer Cells by Increasing COL1A1.

Authors:  Jie Sun; Jie Liu; Qilin Zhu; Feng Xu; Liumin Kang; Xiaohua Shi
Journal:  Onco Targets Ther       Date:  2020-06-30       Impact factor: 4.147

5.  ZBTB7A functioned as an oncogene in colorectal cancer.

Authors:  Li Wang; Meng-Xia Zhang; Mei-Fang Zhang; Zi-Wei Tu
Journal:  BMC Gastroenterol       Date:  2020-11-09       Impact factor: 3.067

Review 6.  Stem cells as therapeutic targets in colorectal cancer.

Authors:  Alicja Zalewski; Adam E Snook; Scott A Waldman
Journal:  Per Med       Date:  2021-02-10       Impact factor: 2.119

7.  MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.

Authors:  Limin Liu; Yulei Li; Ruifang Zhang; Chun Li; Jing Xiong; Yuan Wei
Journal:  BMC Pulm Med       Date:  2020-06-08       Impact factor: 3.317

8.  A Positive Tetraspanin 8 (TSPAN8)/β-Catenin Regulatory Loop Enhances the Stemness of Colorectal Cancer Cells.

Authors:  Zhengyu Zhan; Luxing Zhong; Miao Feng; Yuling Guo
Journal:  Med Sci Monit       Date:  2019-12-15

9.  MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer.

Authors:  Xiao-Liang Xing; Zhi-Yong Yao; Ti Zhang; Ning Zhu; Yuan-Wu Liu; Jing Peng
Journal:  Biomed Res Int       Date:  2020-09-09       Impact factor: 3.411

Review 10.  Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.

Authors:  Julia López de Andrés; Carmen Griñán-Lisón; Gema Jiménez; Juan Antonio Marchal
Journal:  J Hematol Oncol       Date:  2020-10-15       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.